Assignee
NOVAGEN HOLDING CORP
KY·11 granted patents·3 pending applications·70 citations·filing 2006–2022
Top patents by PatentIndex Score
14 records- 0196US7625564B2Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivoNOVAGEN HOLDING CORP·Filed 2006·Granted Dec 1, 2009·41 cites·34 claims
- 0291US7625555B2Recombinant human interferon-like proteinsNOVAGEN HOLDING CORP·Filed 2007·Granted Dec 1, 2009·13 cites·34 claims
- 0386US9375487B2Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivoNOVAGEN HOLDING CORP·Filed 2013·Granted Jun 28, 2016·5 cites·10 claims
- 0484US11279742B2Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivoNOVAGEN HOLDING CORP·Filed 2018·Granted Mar 22, 2022·1 cites·20 claims
- 0584US7964375B2Polynucleotides encoding human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivoNOVAGEN HOLDING CORP·Filed 2009·Granted Jun 21, 2011·4 cites·11 claims
- 0681US2023265143A1Recombinant human epo-fc-fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivoNOVAGEN HOLDING CORP·Filed 2022·Application pending·0 cites
- 0780US7868151B2Recombinant human interferon-like proteinsNOVAGEN HOLDING CORP·Filed 2009·Granted Jan 11, 2011·2 cites·14 claims
- 0879US9234022B2Recombinant human interferon-like proteins and method of treatment using themNOVAGEN HOLDING CORP·Filed 2013·Granted Jan 12, 2016·2 cites·42 claims
- 0978US7867482B2Recombinant human interferon-like proteinsNOVAGEN HOLDING CORP·Filed 2009·Granted Jan 11, 2011·2 cites·30 claims
- 1073US2020369741A1Recombinant human interferon-like proteinsNOVAGEN HOLDING CORP·Filed 2019·Application pending·0 cites
- 1169US10538565B2Method of treating diseases with recombinant human interferon-like proteinsNOVAGEN HOLDING CORP·Filed 2018·Granted Jan 21, 2020·0 cites·14 claims
- 1268US2022127623A1Fusion proteins having mutated immunoglobulin hinge regionNOVAGEN HOLDING CORP·Filed 2021·Application pending·0 cites
- 1364US10233223B2Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivoNOVAGEN HOLDING CORP·Filed 2016·Granted Mar 19, 2019·0 cites·5 claims
- 1462US9982028B2Recombinant human interferon-like proteinsNOVAGEN HOLDING CORP·Filed 2016·Granted May 29, 2018·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when NOVAGEN HOLDING CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →